Overview
Septal fibrosis of the liver involves excessive accumulation of extracellular matrix proteins, primarily driven by activated hepatic stellate cells or myofibroblasts, leading to organ dysfunction and portal hypertension 14.Diagnosis
Imaging Techniques: Magnetic resonance elastography (MRE) can quantitatively measure liver stiffness, aiding in the detection of fibrosis 2.
Biopsy Analysis: Immunohistochemical examination of ECM proteins (collagen I, III, IV, fibronectin, laminin) can differentiate neonatal from adult fibrosis patterns 3.
Grading: Fibrosis staging systems (e.g., METAVIR, Ishvara) are used to assess the severity based on histological findings 3.Management
Antifibrotic Agents: Development of agents targeting apoptosis resistance in hepatic stellate cells is ongoing; specific drug classes and doses are not yet established 1.
Surgical Interventions: Distal splenorenal shunt (DSRS) is effective for managing variceal bleeding in schistosomal hepatic fibrosis without cirrhosis, with low operative mortality and high patency rates 5.
Monitoring: Regular assessment of liver function tests and imaging to monitor disease progression and shunt patency 5.Special Populations
Pediatrics: Neonatal fibrosis shows distinct ECM protein expression patterns compared to adults, particularly in perisinusoidal spaces 3.
Comorbidities: Schistosomal hepatic fibrosis may benefit from surgical interventions like DSRS, showing better survival rates compared to cirrhosis patients 5.Key Recommendations
Utilize magnetic resonance elastography for noninvasive assessment of liver stiffness in diagnosing septal fibrosis (Evidence: Moderate 2).
Consider distal splenorenal shunt for managing variceal bleeding in patients with schistosomal hepatic fibrosis without cirrhosis, given its efficacy and low complication rates (Evidence: Moderate 5).
Differentiate neonatal liver fibrosis from adult patterns through immunohistochemical analysis of ECM proteins, recognizing unique expression profiles (Evidence: Moderate 3).References
1 Kawada N. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease. Gut 2006. link
2 Xu L, Gao PY. "Palpation by imaging": magnetic resonance elastography. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2006. link
3 Zeitlin L, Resnick MB, Konikoff F, Schuppan D, Bujanover Y, Lerner A et al.. Divergent patterns of extracellular matrix protein expression in neonatal versus adult liver fibrosis. Pediatric pathology & molecular medicine 2003. link
4 Gressner AM. The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell and tissue research 1998. link
5 Ezzat FA, Abu-Elmagd KM, Aly IY, Aly MA, Fathy OM, el-Barbary MH et al.. Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis. Annals of surgery 1986. link